EBS
Emergent BioSolutions Inc
Price:  
6.47 
USD
Volume:  
2,437,464.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS WACC - Weighted Average Cost of Capital

The WACC of Emergent BioSolutions Inc (EBS) is 6.4%.

The Cost of Equity of Emergent BioSolutions Inc (EBS) is 12.10%.
The Cost of Debt of Emergent BioSolutions Inc (EBS) is 5.50%.

Range Selected
Cost of equity 9.90% - 14.30% 12.10%
Tax rate 16.60% - 26.10% 21.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.1% - 7.7% 6.4%
WACC

EBS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.3 1.69
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.90% 14.30%
Tax rate 16.60% 26.10%
Debt/Equity ratio 2.66 2.66
Cost of debt 4.00% 7.00%
After-tax WACC 5.1% 7.7%
Selected WACC 6.4%